KeyZell start-up plans targets EUR5m in private financing round
KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, has opened a private financing round with a target of raising EUR5 million to boost its project. The funding will be used to finance a human clinical trial with one of its innovative cancer treatments,